Key Highlights

Risk & Performance

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

N/A

2(66.7%)

Phase 4

1(33.3%)

3Total

N/A(2)

Phase 4(1)

Loading network data...

Showing 5 of 5 trials

Health Systems and Policy Contexts of Medical Oxygen

Role: collaborator

Integrated Mapping of Skin-presenting Neglected Tropical Diseases in Liberia

Role: collaborator

Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in Liberia

Role: collaborator

Nutrition Intervention to Address Anemia Among Adolescent Girls in Liberia

Role: collaborator

Liberia Insecticide Treated Durable Wall Linings Study: Protocol for a Cluster Randomised Trial (DL)

Role: collaborator

All 5 trials loaded